2014
DOI: 10.3233/jad-131796
|View full text |Cite
|
Sign up to set email alerts
|

Regional Fluorodeoxyglucose Metabolism and Instrumental Activities of Daily Living across the Alzheimer's Disease Spectrum

Abstract: Background Impairment in instrumental activities of daily living (IADL) begins as individuals with amnestic mild cognitive impairment (MCI) transition to Alzheimer's disease (AD) dementia. IADL impairment in AD dementia has been associated with inferior parietal, inferior temporal, and superior occipital hypometabolism using 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET). Objective To investigate the relationship between regional FDG metabolism and IADL in clinically normal (CN) elderly, MCI… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
27
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 34 publications
(29 citation statements)
references
References 33 publications
2
27
0
Order By: Relevance
“…FDG-PET data were acquired as described previously [11]. A bolus of 5 mCi of 18 F-FDG was injected, in a quiet, dimly lit room, with subjects in the eyes-open state.…”
Section: Methodsmentioning
confidence: 99%
“…FDG-PET data were acquired as described previously [11]. A bolus of 5 mCi of 18 F-FDG was injected, in a quiet, dimly lit room, with subjects in the eyes-open state.…”
Section: Methodsmentioning
confidence: 99%
“…On the other hand, these items might be useful in combination with other items derived from similar analyses in preclinical and prodromal AD clinical trials, which consist of similar samples, as sensitive IADL outcome measures. IADL impairment in individuals across the early AD spectrum, including CN, MCI, and mild AD dementia, has been associated with multiple AD biomarkers, including measures of atrophy, hypometabolism, cortical amyloid, and cerebrospinal fluid amyloid-beta 1-42, total tau, and phospho-tau [28-33]. The current study did not include AD biomarkers in the classification of diagnoses (the classification was based solely on clinical information).…”
Section: Discussionmentioning
confidence: 99%
“…Cortical thickness of regions of interest (ROI) was measured using FreeSurfer Version 5.1 (http://surfer.nmr.mgh.harvard.edu/) [19]. Four ROI chosen based on results of prior analyses of neuroimaging correlates of ADL were assessed [20, [21]: 1) inferior temporal cortex 2) posterior cingulate cortex; 3) medial orbitofrontal cortex; and 4) supramarginal cortex.…”
Section: Methodsmentioning
confidence: 99%